• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞是否会经历表型转换?不完全的癌症干细胞标志物案例。

Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.

机构信息

CNR-IENI, Via R. Cozzi 53, 20125 Milano, Italy.

出版信息

Sci Rep. 2012;2:441. doi: 10.1038/srep00441. Epub 2012 Jun 7.

DOI:10.1038/srep00441
PMID:22679555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3369193/
Abstract

The identification of cancer stem cells in vivo and in vitro relies on specific surface markers that should allow to sort cancer cells in phenotypically distinct subpopulations. Experiments report that sorted cancer cell populations after some time tend to express again all the original markers, leading to the hypothesis of phenotypic switching, according to which cancer cells can transform stochastically into cancer stem cells. Here we explore an alternative explanation based on the hypothesis that markers are not perfect and are thus unable to identify all cancer stem cells. Our analysis is based on a mathematical model for cancer cell proliferation that takes into account phenotypic switching, imperfect markers and error in the sorting process. Our conclusion is that the observation of reversible expression of surface markers after sorting does not provide sufficient evidence in support of phenotypic switching.

摘要

在体内和体外鉴定癌症干细胞依赖于特定的表面标志物,这些标志物应该能够将癌症细胞分为表型不同的亚群。实验报告表明,经过一段时间的分选后,癌细胞群体往往会再次表达所有原始标志物,从而导致表型转换的假说,根据该假说,癌细胞可以随机转化为癌症干细胞。在这里,我们根据标记物不完美的假设,探索了一种替代解释,因此无法识别所有癌症干细胞。我们的分析基于一个考虑表型转换、不完美标记物和分选过程中错误的癌细胞增殖数学模型。我们的结论是,在分选后观察到表面标志物的可逆表达并不能为表型转换提供充分的证据支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/9a877741b30f/srep00441-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/35dcff4d44ad/srep00441-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/38481e58f872/srep00441-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/03de1abcf293/srep00441-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/2474c2333ba5/srep00441-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/e9e476a7fcb4/srep00441-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/2f09d4fed126/srep00441-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/51d0ceb09128/srep00441-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/9a877741b30f/srep00441-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/35dcff4d44ad/srep00441-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/38481e58f872/srep00441-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/03de1abcf293/srep00441-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/2474c2333ba5/srep00441-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/e9e476a7fcb4/srep00441-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/2f09d4fed126/srep00441-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/51d0ceb09128/srep00441-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/3369193/9a877741b30f/srep00441-f8.jpg

相似文献

1
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.癌细胞是否会经历表型转换?不完全的癌症干细胞标志物案例。
Sci Rep. 2012;2:441. doi: 10.1038/srep00441. Epub 2012 Jun 7.
2
Cancer Stem Cells.癌症干细胞
Recent Results Cancer Res. 2016;198:25-44. doi: 10.1007/978-3-662-49651-0_2.
3
Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.癌细胞系是否具有固定或波动的干细胞表型?——以 NTera2 细胞系为例的研究。
Stem Cell Rev Rep. 2017 Oct;13(5):603-610. doi: 10.1007/s12015-017-9743-3.
4
Complexity in cancer stem cells and tumor evolution: Toward precision medicine.癌症干细胞和肿瘤演化的复杂性:迈向精准医学。
Semin Cancer Biol. 2017 Jun;44:3-9. doi: 10.1016/j.semcancer.2017.02.007. Epub 2017 Feb 23.
5
Cancer stem cell targeted therapy: progress amid controversies.癌症干细胞靶向治疗:争议中取得的进展
Oncotarget. 2015 Dec 29;6(42):44191-206. doi: 10.18632/oncotarget.6176.
6
Searching for prostate cancer stem cells: markers and methods.寻找前列腺癌干细胞:标志物和方法。
Stem Cell Rev Rep. 2013 Oct;9(5):721-30. doi: 10.1007/s12015-013-9453-4.
7
Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.转移性结肠癌干细胞的表型亚群:基因组分析
Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.
8
Cancer stem cells: distinct entities or dynamically regulated phenotypes?癌症干细胞:独特的实体还是动态调节的表型?
Cancer Res. 2012 Feb 1;72(3):576-80. doi: 10.1158/0008-5472.CAN-11-3070.
9
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.迭代分选揭示CD133 +和CD133 -黑色素瘤细胞为表型不同的群体。
BMC Cancer. 2016 Sep 9;16(1):726. doi: 10.1186/s12885-016-2759-2.
10
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.简明综述:CD44在癌症干细胞中的新兴作用:一种有前景的生物标志物和治疗靶点
Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1.

引用本文的文献

1
MicroRNA-222 Regulates Melanoma Plasticity.微小RNA-222调控黑色素瘤可塑性。
J Clin Med. 2020 Aug 8;9(8):2573. doi: 10.3390/jcm9082573.
2
Mitochondrial Stress-Mediated Targeting of Quiescent Cancer Stem Cells in Oral Squamous Cell Carcinoma.线粒体应激介导的口腔鳞状细胞癌中静止癌症干细胞的靶向作用
Cancer Manag Res. 2020 Jun 15;12:4519-4530. doi: 10.2147/CMAR.S252292. eCollection 2020.
3
The effects of phenotypic plasticity on the fixation probability of mutant cancer stem cells.表型可塑性对突变癌干细胞固定概率的影响。

本文引用的文献

1
Optimality in the development of intestinal crypts.肠道隐窝发育的最优性。
Cell. 2012 Feb 3;148(3):608-19. doi: 10.1016/j.cell.2011.12.025.
2
Senescent cells in growing tumors: population dynamics and cancer stem cells.生长肿瘤中的衰老细胞:群体动力学与癌症干细胞。
PLoS Comput Biol. 2012 Jan;8(1):e1002316. doi: 10.1371/journal.pcbi.1002316. Epub 2012 Jan 19.
3
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.随机状态转变导致癌细胞群体中的表型平衡。
J Theor Biol. 2020 Oct 21;503:110384. doi: 10.1016/j.jtbi.2020.110384. Epub 2020 Jun 27.
4
Head and neck cancer management and cancer stem cells implication.头颈癌的治疗与癌症干细胞的影响
Saudi Dent J. 2019 Oct;31(4):395-416. doi: 10.1016/j.sdentj.2019.05.010. Epub 2019 Jun 10.
5
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.通过靶向NANOG的细胞毒性T淋巴细胞对癌症干细胞的免疫抑制
Front Immunol. 2018 Jun 19;9:1412. doi: 10.3389/fimmu.2018.01412. eCollection 2018.
6
Phenotypic Switching Can Speed up Microbial Evolution.表型转换可以加速微生物进化。
Sci Rep. 2018 Jun 12;8(1):8941. doi: 10.1038/s41598-018-27095-9.
7
Phenotypic heterogeneity in modeling cancer evolution.癌症进化建模中的表型异质性。
PLoS One. 2017 Oct 30;12(10):e0187000. doi: 10.1371/journal.pone.0187000. eCollection 2017.
8
Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.分泌型卷曲相关蛋白 4(sFRP4)可使源自人乳腺癌、前列腺癌和卵巢癌细胞系的肿瘤干细胞对化疗药物敏感。
Sci Rep. 2017 May 23;7(1):2256. doi: 10.1038/s41598-017-02256-4.
9
Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity.干细胞与非干细胞癌细胞群体的双向相互转化:对肿瘤异质性理论模型的重新评估。
Mol Cell Oncol. 2015 Dec 2;3(2):e1098791. doi: 10.1080/23723556.2015.1098791. eCollection 2016 Mar.
10
Overshoot during phenotypic switching of cancer cell populations.癌细胞群体表型转换期间的超调现象。
Sci Rep. 2015 Oct 23;5:15464. doi: 10.1038/srep15464.
Cell. 2011 Aug 19;146(4):633-44. doi: 10.1016/j.cell.2011.07.026.
4
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.CD44(+)/CD24(-/low) 癌症干细胞/祖细胞在三阴性浸润性乳腺癌表型中更为丰富,并与不良预后相关。
Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.
5
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.CXCR6,一种新定义的组织特异性干细胞不对称自我更新的生物标志物,可鉴定侵袭性更强的人类黑色素瘤癌症干细胞。
PLoS One. 2010 Dec 22;5(12):e15183. doi: 10.1371/journal.pone.0015183.
6
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.潘氏细胞构成了肠道隐窝中 Lgr5 干细胞的龛位。
Nature. 2011 Jan 20;469(7330):415-8. doi: 10.1038/nature09637. Epub 2010 Nov 28.
7
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.肿瘤发生性黑色素瘤细胞在患者之间存在表型异质性,这种异质性是可逆的,且不是层次组织的。
Cancer Cell. 2010 Nov 16;18(5):510-23. doi: 10.1016/j.ccr.2010.10.012.
8
Intestinal stem cell replacement follows a pattern of neutral drift.肠干细胞的更替遵循中性漂移模式。
Science. 2010 Nov 5;330(6005):822-5. doi: 10.1126/science.1196236. Epub 2010 Sep 23.
9
Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells.肠隐窝稳态源自对称分裂的 Lgr5 干细胞之间的中性竞争。
Cell. 2010 Oct 1;143(1):134-44. doi: 10.1016/j.cell.2010.09.016.
10
Role of symmetric and asymmetric division of stem cells in developing drug resistance.干细胞的对称和不对称分裂在产生药物抗性中的作用。
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16766-71. doi: 10.1073/pnas.1007726107. Epub 2010 Sep 8.